I very much hope you're right ajk and l do completely understand your rationale however my comments are drawn from past experience with biotechs where good phase 1 results have only resulted in a short term spike in the SP regardless of any compelling evidence such as you have outlined in this instance. Like l said the market is very conservative these days, just look at the reaction to the BV results. Much less than we all predicted beforehand.
Value - a tough one to work out, page-16
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
